Restoring retinoic acid attenuates intestinal inflammation and tumorigenesis in APCMin/+ mice

Cancer Immunology Research

Volumn 4, Issue 11, 2016, Pages 917-926

  Penny, Hweixian Leong ^a   Prestwood, Tyler R ^a   Bhattacharya, Nupur ^a   Sun, Fionna ^a   Kenkel, Justin A ^a   Davidson, Matthew G ^a   Shen, Lei ^a   Zuniga, Luis A ^b   Seeley, E Scott ^a   Pai, Reetesh ^a   Choi, Okmi ^a   Tolentino, Lorna ^a   Wang, Jinshan ^c   Napoli, Joseph L ^c   Engleman, Edgar G ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 26A1; LIAROZOLE; RETINOIC ACID; RETINOL; TALAROZOLE; ANTINEOPLASTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CATABOLISM; CONTROLLED STUDY; DENDRITIC CELL; ENTERITIS; FAMILIAL COLON POLYPOSIS; FEMALE; FLOW CYTOMETRY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNE SYSTEM; IMMUNOBLOTTING; IN VITRO STUDY; INTESTINE TISSUE; LAMINA PROPRIA; LYMPHOCYTE DIFFERENTIATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MOUSE; NONHUMAN; PHENOTYPE; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY T LYMPHOCYTE; RETINOL DEFICIENCY; SMALL INTESTINE; TH17 CELL; TUMOR VOLUME; ADENOMA; ANIMAL; CELL TRANSFORMATION; COLON POLYPOSIS; COLORECTAL TUMOR; COMPLICATION; DRUG EFFECTS; ENTEROCOLITIS; GENETICS; IMMUNOLOGY; METABOLISM; PATHOLOGY; TUMOR SUPPRESSOR GENE;

ADENOMA; ADENOMATOUS POLYPOSIS COLI; ANIMALS; ANTINEOPLASTIC AGENTS; CELL TRANSFORMATION, NEOPLASTIC; COLORECTAL NEOPLASMS; DENDRITIC CELLS; ENTEROCOLITIS; GENES, APC; HUMANS; MICE; PHENOTYPE; TH17 CELLS; TRETINOIN; TUMOR BURDEN; VITAMIN A; VITAMIN A DEFICIENCY;

EID: 85016143805     PISSN: 23266066     EISSN: 23266074     Source Type: Journal    
DOI: 10.1158/2326-6066.CIR-15-0038     Document Type: Article

References (52)

1. Ullman TA, Itzkowitz SH. Intestinal Inflammation and Cancer. Gastroenterology 2011;140:1807-16.e1.
2. Kinzler KW, Nilbert MC, Vogelstein B, Bryan TM, Levy DB, Smith KJ, et al. Identification of a gene located at chromosome 5q21 that is mutated in colorectal cancers. Science 1991;251:1366-70.
3. Groden J, Thliveris A, Samowitz W, CarlsonM,Gelbert L, Albertsen H, et al. Identification and characterization of the familial adenomatous polyposis coli gene. Cell 1991;66:589-600.
4. Powell SM, Zilz N, Beazer-Barclay Y, Bryan TM, Hamilton SR, Thibodeau SN, et al. APC mutations occur early during colorectal tumorigenesis. Nature 1992;359:235-7.
5. Abu-Abed SS, Beckett BR, Chiba H, Chithalen JV, Jones G,Metzger D, et al. Mouse P450RAI (CYP26) expression and retinoic acid-inducible retinoic acid metabolism in F9 cells are regulated by retinoic acid receptor gamma and retinoid X receptor alpha. J Biol Chem 1998;273:2409-15.
6. Lynch PM. Pharmacotherapy for inherited colorectal cancer. Expert Opin Pharmacother 2010;11:1101-8.
7. Erdman SE, Sohn JJ, Rao VP, Nambiar PR, Ge Z, Fox JG, et al. CD4+CD25+ regulatory lymphocytes induce regression of intestinal tumors in ApcMin/+ mice. Cancer Res 2005;65:3998-4004.
8. Gounaris E, Blatner NR, Dennis K, Magnusson F, Gurish MF, Strom TB, et al. T-regulatory cells shift from a protective anti-inflammatory to a cancerpromoting proinflammatory phenotype in polyposis. Cancer Res 2009;69: 5490-7.
9. Chae WJ, Gibson TF, Zelterman D, Hao L, Henegariu O, Bothwell AL. Ablation of IL-17A abrogates progression of spontaneous intestinal tumorigenesis. Proc Natl Acad Sci U S A 2010;107:5540-4.
10. Niederreither K, Dolle P. Retinoic acid in development: towards an integrated view. Nat Rev Genet 2008;9:541-53.
11. Hall JA, Grainger JR, Spencer SP, Belkaid Y. The role of retinoic acid in tolerance and immunity. Immunity 2011;35:13-22.
12. Coombes JL, Siddiqui KR, Arancibia-Carcamo CV, Hall J, Sun CM, Belkaid Y, et al. A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-b and retinoic acid-dependent mechanism. J Exp Med 2007;204: 1757-64.
13. Benson MJ, Pino-Lagos K, Rosemblatt M, Noelle RJ. All-trans retinoic acid mediates enhanced T reg cell growth, differentiation, and gut homing in the face of high levels of co-stimulation. J Exp Med 2007;2041765-74.
14. Mucida D, Park Y, Kim G, Turovskaya O, Scott I, Kronenberg M, et al. Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 2007;317:256-60.
15. Sun C-M, Hall JA, Blank RB, Bouladoux N, Oukka M, Mora JR, et al. Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J Exp Med 2007;204:1775-85.
16. Blomhoff R, Blomhoff HK. Overviewof retinoid metabolism and function. J Neurobiol 2006;66:606-30.
17. Kane MA, Folias AE, Wang C, Napoli JL. Quantitative profiling of endogenous retinoic acid in vivo and in vitro by tandemmass spectrometry. Anal Chem 2008;80:1702-8.
18. Kane MA, Folias AE, Wang C, Napoli JL. Ethanol elevates physiological alltrans-retinoic acid levels in select loci through altering retinoidmetabolism in multiple loci: a potential mechanism of ethanol toxicity. FASEB J 2010;24:823-32.
19. Kane MA, Folias AE, Napoli JL. HPLC/UV quantitation of retinal, retinol, and retinyl esters in serum and tissues. Anal Biochem 2008;378:71-9.
20. Shelton DN, Sandoval IT, Eisinger A, Chidester S, Ratnayake A, Ireland CM, et al. Up-regulation of CYP26A1 in adenomatous polyposis coli-deficient vertebrates via a WNT-dependent mechanism: implications for intestinal cell differentiation and colon tumor development. Cancer Res 2006;66: 7571-7.
21. Nadauld LD, Phelps R,Moore BC, Eisinger A, Sandoval IT, Chidester S, et al. Adenomatous polyposis coli control of C-terminal binding protein-1 stability regulates expression of intestinal retinol dehydrogenases. J Biol Chem 2006;281:37828-35.
22. Parés X, Farrés J, Kedishvili N, Duester G. Medium-and short-chain dehydrogenase/reductase gene and protein families. Cell Mol Life Sci 2008;65:3936-49.
23. Verfaille CJ, Vanhoutte FP, Blanchet-Bardon C, Van Steensel MA, Steijlen PM. Oral liarozole vs. acitretin in the treatment of ichthyosis: a phase II/III multicentre, double-blind, randomized, active-controlled study. Br J Dermatol 2007;156:965-73.
24. Baert B, De Spiegeleer B. Local skin pharmacokinetics of talarozole, a new retinoic acid metabolism-blocking agent. Skin Pharmacol Physiol 2011;24:151-9.
25. Gottschalk RA, Corse E, Allison JP. TCR ligand density and affinity determine peripheral induction of Foxp3 in vivo. J Exp Med 2010;207: 1701-11.
26. Long SA, Rieck M, Tatum M, Bollyky PL, Wu RP, Muller I, et al. Low-dose antigen promotes induction of FOXP3 in human CD4+ T cells. J Immunol 2011;187:3511-20.
27. Turner MS, Kane LP, Morel PA. Dominant role of antigen dose in CD4+ Foxp3+ regulatory T cell induction and expansion. J Immunol 2009;183: 4895-903.
28. Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 2006;24:179-89.
29. Vaglenova J, Martínez SE, Porté S, Duester G, Farrés J, Parés X. Expression, localization and potential physiological significance of alcohol dehydrogenase in the gastrointestinal tract. Eur J Biochem 2003;270:2652-62.
30. Yang QJ, Zhou LY, Mu YQ, Zhou QX, Luo JY, Cheng L, et al. All-trans retinoic acid inhibits tumor growth of human osteosarcoma by activating Smad signaling-induced osteogenic differentiation. Int J Oncol 2012;41: 153-60.
31. Zhu WY, Jones CS, Kiss A, Matsukuma K, Amin S, De Luca LM. Retinoic acid inhibition of cell cycle progression inMCF-7human breast cancer cells. Exp Cell Res 1997;234:293-9.
32. Wang Q, Yang W, Uytingco MS, Christakos S, Wieder R. 1,25-Dihydroxyvitamin D3 and all-trans-retinoic acid sensitize breast cancer cells to chemotherapy-induced cell death. Cancer Res 2000;60:2040-8.
33. Hoffmann S, Rockenstein A, Ramaswamy A, Celik I, Wunderlich A, Lingelbach S, et al. Retinoic acid inhibits angiogenesis and tumor growth of thyroid cancer cells. Mol Cell Endocrinol 2007;264:74-81.
34. Lim YC, Kang HJ, Kim YS, Choi EC. All-trans-retinoic acid inhibits growth of head and neck cancer stem cells by suppression of Wnt/beta-catenin pathway. Eur J Cancer 2012;48:3310-8.
35. Zheng Y, Kramer PM, Olson G, Lubet RA, Steele VE, Kelloff GJ, et al. Prevention by retinoids of azoxymethane-induced tumors and aberrant crypt foci and their modulation of cell proliferation in the colon of rats. Carcinogenesis 1997;18:2119-25.
36. Corpet DE, Pierre F. Point: From animal models to prevention of colon cancer. Systematic review of chemoprevention in min mice and choice of the model system. Cancer Epidemiol Biomarkers Prev 2003; 12:391-400.
37. Coletta PL, Muller AM, Jones EA, Muhl B, Holwell S, Clarke D, et al. Lymphodepletion in the ApcMin/+ mouse model of intestinal tumorigenesis. Blood 2004;103:1050-8.
38. Rao VP, Poutahidis T, Ge Z, Nambiar PR, Horwitz BH, Fox JG, et al. Proinflammatory CD4+ CD45RB(hi) lymphocytes promote mammary and intestinal carcinogenesis in Apc(Min/+) mice. Cancer Res 2006;66: 57-61.
39. Annacker O, Coombes JL, Malmstrom V, Uhlig HH, Bourne T, Johansson-LindbomB, et al. Essential role for CD103 in the T cell-mediated regulation of experimental colitis. J Exp Med 2005;202:1051-61.
40. Tada Y, Asahina A, Fujita H, Mitsui H, Torii H, Watanabe T, et al. Differential effects of LPS and TGF-beta on the production of IL-6 and IL-12 by Langerhans cells, splenic dendritic cells, and macrophages. Cytokine 2004;25:155-61.
41. Mowat AM, Bain CC. Mucosal macrophages in intestinal homeostasis and inflammation. J Innate Immun 2011;3:550-64.
42. Zheng Y, Danilenko DM, Valdez P, Kasman I, Eastham-Anderson J, Wu J, et al. Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 2007;445:648-51.
43. Huber S, Gagliani N, Zenewicz LA, Huber FJ, Bosurgi L, Hu B, et al. IL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestine. Nature 2012;491:259-63.
44. Martin JC, BeriouG,HeslanM, Chauvin C, Utriainen L, Aumeunier A, et al. Interleukin-22 binding protein (IL-22BP) is constitutively expressed by a subset of conventional dendritic cells and is strongly induced by retinoic acid. Mucosal Immunol 2014;7:101-13.
45. Klebanoff CA, Spencer SP, Torabi-Parizi P, Grainger JR, Roychoudhuri R, Ji Y, et al. Retinoic acid controls the homeostasis of pre-cDC-derived splenic and intestinal dendritic cells. J Exp Med 2013;210: 1961-76.
46. Mollersen L, Paulsen JE, Olstorn HB, Knutsen HK, Alexander J. Dietary retinoic acid supplementation stimulates intestinal tumour formation and growth in multiple intestinal neoplasia (Min)/+ mice. Carcinogenesis 2004;25:149-53.
47. Stoppie P, Borgers M, Borghgraef P, Dillen L, Goossens J, Sanz G, et al. R115866 inhibits all-trans-retinoic acid metabolism and exerts retinoidal effects in rodents. J Pharmacol Exp Ther 2000;293:304-12.
48. Iwata M, Hirakiyama A, Eshima Y, Kagechika H, Kato C, Song SY. Retinoic acid imprints gut-homing specificity on T cells. Immunity 2004;21: 527-38.
49. Reddy D, Siegel CA, Sands BE, Kane S. Possible association between isotretinoin and inflammatory bowel disease. Am J Gastroenterol 2006; 101:1569-73.
50. DePaolo RW, Abadie V, Tang F, Fehlner-Peach H, Hall JA, Wang W, et al. Co-adjuvant effects of retinoic acid and IL-15 induce inflammatory immunity to dietary antigens. Nature 2011;471:220-4.
51. Seidmon EJ, Trump DL, Kreis W, Hall SW, Kurman MR, Ouyang SP, et al. Phase I/II dose-escalation study of liarozole in patients with stage D, hormone-refractory carcinoma of the prostate. Ann Surg Oncol 1995; 2:550-6.
52. Verfaille CJ, Thissen CA, Bovenschen HJ, Mertens J, Steijlen PM, van de Kerkhof PC. Oral R115866 in the treatment of moderate to severe plaquetype psoriasis. J Eur Acad Dermatol Venereol 2007;21:1038-46.